Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Islet cell transplantation.

Literature DB >> 11773349

Islet cell transplantation.

Terry Samuel¹, Paul Cockwell.

Abstract

Entities: Chemical

Mesh：

Substances：
Immunosuppressive Agents

Year: 2002 PMID： 11773349 PMCID： PMC1279145 DOI： 10.1177/014107680209500109

Source DB: PubMed Journal: J R Soc Med ISSN： 0141-0768 Impact factor: 18.000

× No keyword cloud information.

17 in total

1. Sirolimus (rapamycin)-based therapy in human renal transplantation: similar efficacy and different toxicity compared with cyclosporine. Sirolimus European Renal Transplant Study Group.

Authors: C G Groth; L Bäckman; J M Morales; R Calne; H Kreis; P Lang; J L Touraine; K Claesson; J M Campistol; D Durand; L Wramner; C Brattström; B Charpentier
Journal: Transplantation Date: 1999-04-15 Impact factor: 4.939

2. Reversal of insulin-dependent diabetes using islets generated in vitro from pancreatic stem cells.

Authors: V K Ramiya; M Maraist; K E Arfors; D A Schatz; A B Peck; J G Cornelius
Journal: Nat Med Date: 2000-03 Impact factor: 53.440

3. Sirolimus-tacrolimus combination immunosuppression.

Authors: V C McAlister; Z Gao; K Peltekian; J Domingues; K Mahalati; A S MacDonald
Journal: Lancet Date: 2000-01-29 Impact factor: 79.321

4. Transplantation of allogeneic islets of Langerhans in the rat liver: effects of macrophage depletion on graft survival and microenvironment activation.

Authors: R Bottino; L A Fernandez; C Ricordi; R Lehmann; M F Tsan; R Oliver; L Inverardi
Journal: Diabetes Date: 1998-03 Impact factor: 9.461

5. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen.

Authors: A M Shapiro; J R Lakey; E A Ryan; G S Korbutt; E Toth; G L Warnock; N M Kneteman; R V Rajotte
Journal: N Engl J Med Date: 2000-07-27 Impact factor: 91.245

6. In vitro cultivation of human islets from expanded ductal tissue.

Authors: S Bonner-Weir; M Taneja; G C Weir; K Tatarkiewicz; K H Song; A Sharma; J J O'Neil
Journal: Proc Natl Acad Sci U S A Date: 2000-07-05 Impact factor: 11.205

7. Insulin-secreting cells derived from embryonic stem cells normalize glycemia in streptozotocin-induced diabetic mice.

Authors: B Soria; E Roche; G Berná; T León-Quinto; J A Reig; F Martín
Journal: Diabetes Date: 2000-02 Impact factor: 9.461

8. Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation. Daclizumab Triple Therapy Study Group.

Authors: F Vincenti; R Kirkman; S Light; G Bumgardner; M Pescovitz; P Halloran; J Neylan; A Wilkinson; H Ekberg; R Gaston; L Backman; J Burdick
Journal: N Engl J Med Date: 1998-01-15 Impact factor: 91.245

Islet cell transplantation.

1. Sirolimus (rapamycin)-based therapy in human renal transplantation: similar efficacy and different toxicity compared with cyclosporine. Sirolimus European Renal Transplant Study Group.

2. Reversal of insulin-dependent diabetes using islets generated in vitro from pancreatic stem cells.

3. Sirolimus-tacrolimus combination immunosuppression.

4. Transplantation of allogeneic islets of Langerhans in the rat liver: effects of macrophage depletion on graft survival and microenvironment activation.

5. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen.

6. In vitro cultivation of human islets from expanded ductal tissue.

7. Insulin-secreting cells derived from embryonic stem cells normalize glycemia in streptozotocin-induced diabetic mice.

8. Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation. Daclizumab Triple Therapy Study Group.

9. Involvement of O2 radicals in 'autoimmune' diabetes.

10. Combined treatment with nicotinamide and desferrioxamine prevents islet allograft destruction in NOD mice.

1. Prevention of primary non-function of islet xenografts in autoimmune diabetic NOD mice by anti-inflammatory agents.

Review 2. Immunomodulatory Effects of Genetic Alterations Affecting the Kynurenine Pathway.